| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 187,026 | 234,991 | 262,627 | | Cost of Revenue | 175,941 | 210,715 | 220,901 | | | Gross Profit | 11,085 | 24,276 | 41,726 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 33,888 | 36,510 | 33,669 | | Non Recurring | 4,706 | 1,319 | 592 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (27,509) | (13,553) | 7,465 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,949 | 2,529 | 1,079 | | Earnings Before Interest And Taxes | (25,560) | (10,694) | 8,544 | | Interest Expense | 68 | 127 | 109 | | Income Before Tax | (25,628) | (10,821) | 8,435 | | Income Tax Expense | 7,483 | (4,357) | 2,311 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (33,111) | (6,464) | 6,124 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (33,111) | (6,464) | 6,124 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($33,111) | ($6,464) | $6,124 |
|
0.51% Nasdaq 
Income Statement
